The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting

BACKGROUND: Novel treatment strategies are needed to cure disseminated Ewing sarcoma. Primitive neuroectodermal features and a mesenchymal stem cell origin are both compatible with aberrant expression of the ganglioside antigen G(D2) and led us to explore G(D2) immune targeting in this cancer. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Kailayangiri, S, Altvater, B, Meltzer, J, Pscherer, S, Luecke, A, Dierkes, C, Titze, U, Leuchte, K, Landmeier, S, Hotfilder, M, Dirksen, U, Hardes, J, Gosheger, G, Juergens, H, Rossig, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304425/
https://www.ncbi.nlm.nih.gov/pubmed/22374462
http://dx.doi.org/10.1038/bjc.2012.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304425/
https://www.ncbi.nlm.nih.gov/pubmed/22374462
http://dx.doi.org/10.1038/bjc.2012.57

Ejemplares similares